FDA label
What is Skyrizi used for?
Skyrizi contains risankizumab. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Skyrizi lists 4 uses: Plaque Psoriasis; Psoriatic Arthritis; Crohn’s Disease; Ulcerative Colitis.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Skyrizi?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Skyrizi, injection
Indications and Usage, quoted from the label by AbbVie Inc. (BLA761105). Cross-references to other label sections are left out.
Plaque Psoriasis
SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 6 years of age and older who are candidates for systemic therapy or phototherapy.
Psoriatic Arthritis
SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults and pediatric patients 6 years of age and older.
Crohn’s Disease
SKYRIZI is indicated for the treatment of moderately to severely active Crohn's disease in adults.
Ulcerative Colitis
SKYRIZI is indicated for the treatment of moderately to severely active ulcerative colitis in adults.
Source: DailyMed label, set id 7148c8eb-b39e-e20a-6494-a6df82392858, version 179, effective June 15, 2026. NDC 0074-1050, one of 5 listings for this product.
Questions
What is Skyrizi used for?
The FDA label for Skyrizi lists 4 uses: Plaque Psoriasis; Psoriatic Arthritis; Crohn’s Disease; Ulcerative Colitis.
What drug class is Skyrizi?
FDA lists risankizumab in the Interleukin-23 Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.